The best seasonal allergy medication depends on your specific symptoms, their severity, and any underlying health conditions. Seasonal allergies — most commonly hay fever (allergic rhinitis) — affect millions of people across the UK each year, causing sneezing, nasal congestion, itchy eyes, and fatigue during pollen season. Fortunately, a range of effective treatments is available, from non-sedating antihistamines and intranasal corticosteroid sprays to targeted eye drops and, in severe cases, allergen immunotherapy. This guide covers the main medication options available in the UK, how to use them safely, and when to seek further advice from a pharmacist or GP.
Summary: The best seasonal allergy medication depends on symptom severity: non-sedating antihistamines suit mild cases, while intranasal corticosteroid sprays are the most effective single treatment for moderate-to-severe hay fever, according to NICE guidance.
- Second-generation antihistamines (cetirizine, loratadine, fexofenadine) are preferred over sedating first-generation options such as chlorphenamine for hay fever.
- Intranasal corticosteroid sprays (e.g., beclometasone, fluticasone) are the most effective treatment for persistent or moderate-to-severe allergic rhinitis per NICE CKS.
- Nasal decongestant sprays must not be used for more than 7 consecutive days due to the risk of rebound congestion (rhinitis medicamentosa).
- Fexofenadine absorption is significantly reduced by fruit juices; it should always be taken with water.
- Loratadine or cetirizine are the preferred oral antihistamines in pregnancy; always seek pharmacist or GP advice before starting treatment when pregnant or breastfeeding.
- Allergen immunotherapy (SCIT or SLIT) may be considered via specialist referral for patients who do not respond adequately to optimised pharmacotherapy.
Table of Contents
- Understanding Seasonal Allergies and Their Symptoms
- Types of Seasonal Allergy Medication Available in the UK
- Antihistamines, Nasal Sprays and Eye Drops: What to Choose
- NHS and NICE Guidance on Treating Hay Fever and Allergies
- How to Use Allergy Medications Safely and Effectively
- Frequently Asked Questions
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
Understanding Seasonal Allergies and Their Symptoms
Seasonal allergies (hay fever) occur when the immune system overreacts to airborne pollens, triggering histamine release and causing sneezing, nasal congestion, itchy eyes, and fatigue; they can also worsen underlying asthma.
Not sure if this is normal? Chat with one of our pharmacists →
Seasonal allergies, most commonly known as hay fever (allergic rhinitis), are among the most prevalent conditions in the UK, affecting a substantial proportion of adults and children — estimates vary, but UK and global data suggest figures in the range of 10–30% of adults and up to 40% of children, though prevalence varies by region and pollen exposure. Hay fever occurs when the immune system overreacts to airborne allergens such as tree pollen (typically February to June), grass pollen (May to July), and weed pollen (June to September), according to the Met Office UK pollen calendar. The body releases histamine and other inflammatory mediators in response, triggering a cascade of familiar symptoms.
The most common symptoms include:
-
Sneezing and a runny or blocked nose
-
Itchy, red, or watery eyes (allergic conjunctivitis)
-
Itching of the throat, mouth, ears, or skin
-
Postnasal drip and mild fatigue
In some individuals, seasonal allergies can worsen underlying asthma, causing increased breathlessness, chest tightness, or wheezing. This overlap — sometimes called 'united airway disease' — is an important clinical consideration. People with asthma should follow their personalised asthma action plan and seek a GP review promptly if hay fever appears to worsen their asthma control (for example, if they are using their reliever inhaler more frequently or experiencing nocturnal symptoms). Symptoms can significantly impair quality of life, affecting sleep, concentration, and daily functioning, particularly during peak pollen seasons.
It is worth noting that not all seasonal nasal or eye symptoms are allergic in origin. Viral upper respiratory infections, non-allergic rhinitis, and irritant exposures can mimic hay fever. If symptoms are persistent, severe, or do not respond to standard treatments, a GP assessment is advisable to confirm the diagnosis and rule out alternative causes.
Seek urgent medical help (call 999 or go to A&E) if you experience: severe or rapidly worsening breathlessness or chest tightness not relieved by a reliever inhaler, swelling of the lips, tongue, or throat, eye pain, photophobia, or any sudden change in vision. These are not typical hay fever symptoms and require prompt assessment.
| Medication Class | Examples (UK) | Best For | Availability | Key Cautions | NICE/MHRA Guidance |
|---|---|---|---|---|---|
| Second-generation oral antihistamines | Cetirizine, loratadine, fexofenadine | Mild, intermittent sneezing, itching, rhinorrhoea | OTC; fexofenadine 120 mg as pharmacy (P) medicine | Fexofenadine absorption reduced by fruit juices; take with water only | Preferred over sedating antihistamines; suitable first-line for mild symptoms |
| Intranasal corticosteroid sprays | Beclometasone, fluticasone, budesonide | Moderate-to-severe nasal blockage and persistent symptoms | OTC or prescription depending on product | Use correct technique; direct away from septum to reduce epistaxis risk | NICE CKS: most effective single treatment for moderate-to-severe allergic rhinitis |
| Topical eye drops (mast cell stabilisers) | Sodium cromoglicate, ketotifen | Itchy, watery, red eyes (allergic conjunctivitis) | OTC; check age limits on label | Sodium cromoglicate requires several-times-daily dosing; takes days for full effect | Recommended alongside intranasal corticosteroid when ocular symptoms are prominent |
| Topical eye drops (antihistamine, prescription) | Azelastine, olopatadine | Moderate-to-severe ocular symptoms unresponsive to OTC drops | Prescription only | Consult GP or ophthalmologist; not for self-treatment of eye pain or vision changes | Consult SmPC; seek urgent care for eye pain, photophobia, or vision change |
| Combination intranasal antihistamine + corticosteroid | Azelastine/fluticasone (e.g., Dymista) | Poorly controlled or complex nasal and ocular symptoms | Prescription only; licensed from age 12 | Not first-line; reserved for inadequate response to individual agents | May benefit patients with more complex symptom profiles per NICE CKS |
| Decongestants | Xylometazoline (nasal), pseudoephedrine (oral) | Short-term nasal congestion relief only | OTC with restrictions; not for under-12s | Max 7 days nasal use; avoid in hypertension, heart disease, pregnancy; MHRA warns of rare RCVS risk with pseudoephedrine | Not recommended for routine hay fever management; significant safety cautions apply |
| Allergen immunotherapy (SCIT/SLIT) | Subcutaneous or sublingual desensitisation | Severe, refractory IgE-mediated allergic rhinitis unresponsive to pharmacotherapy | Specialist referral; NHS availability varies by region | Must be initiated and supervised by specialist; facilities for adverse reactions required | NICE supports referral when optimised pharmacotherapy fails; not a first-line option |
Types of Seasonal Allergy Medication Available in the UK
UK treatments include second-generation oral antihistamines, intranasal corticosteroid sprays, antihistamine or mast cell stabiliser eye drops, decongestants (with important cautions), and allergen immunotherapy for severe cases.
A range of medications is available in the UK to manage seasonal allergies, accessible both over the counter (OTC) at pharmacies and on prescription. The principal classes include oral antihistamines, intranasal corticosteroid sprays, antihistamine and mast cell stabiliser eye drops, decongestants, and — for more severe or refractory cases — allergen immunotherapy.
Oral antihistamines are typically the first-line OTC choice. Second-generation antihistamines such as cetirizine, loratadine, and fexofenadine are preferred over first-generation options (e.g., chlorphenamine) because they cause significantly less sedation and have a longer duration of action, allowing once-daily dosing. Fexofenadine 120 mg tablets are licensed for hay fever in adults and young people aged 12 years and over; some packs are available as pharmacy (P) medicines — check the label or ask your pharmacist.
Intranasal corticosteroid sprays (e.g., beclometasone, fluticasone, budesonide) are considered the most effective single treatment for moderate-to-severe allergic rhinitis according to NICE Clinical Knowledge Summaries (CKS). They work by reducing local mucosal inflammation and are available OTC or on prescription depending on the specific product and formulation.
Eye drops for ocular symptoms include:
-
OTC options: sodium cromoglicate and ketotifen eye drops are available without prescription and are suitable for most adults and children (check age limits on the label).
-
Prescription-only options: azelastine and olopatadine eye drops are generally available on prescription only in the UK.
Decongestants such as pseudoephedrine (oral) or xylometazoline (nasal spray) can relieve nasal congestion but carry important cautions:
-
Nasal decongestant sprays should not be used for more than 7 consecutive days due to the risk of rebound congestion (rhinitis medicamentosa).
-
Oral decongestants are unsuitable for people with hypertension, heart disease, hyperthyroidism, or those taking monoamine oxidase inhibitors (MAOIs).
-
Decongestants should not be used in children under 12 years of age.
-
They should be avoided in pregnancy and breastfeeding unless specifically advised by a clinician.
-
The MHRA and EMA have issued safety advice regarding a rare but serious risk of reversible cerebral vasoconstriction syndrome (RCVS) and posterior reversible encephalopathy syndrome (PRES) associated with pseudoephedrine. Stop use and seek urgent medical attention if you develop a sudden, severe headache or any neurological symptoms (such as confusion, visual disturbance, or weakness) whilst taking pseudoephedrine.
For patients with severe, persistent symptoms unresponsive to pharmacotherapy, allergen immunotherapy (desensitisation) may be considered via specialist referral.
A note on other options: Ipratropium nasal spray (prescription-only) may be considered by a clinician for troublesome watery rhinorrhoea. Leukotriene receptor antagonists such as montelukast are not recommended as first-line treatment for allergic rhinitis; the MHRA has issued guidance on the risk of neuropsychiatric adverse reactions (including sleep disturbances, anxiety, and mood changes) with montelukast, and patients should be counselled accordingly if it is considered.
Experiencing these side effects? Our pharmacists can help you navigate them →
Antihistamines, Nasal Sprays and Eye Drops: What to Choose
Mild intermittent symptoms are best managed with a non-sedating antihistamine, while moderate-to-severe or persistent nasal symptoms require a regular intranasal corticosteroid spray, ideally started 1–2 weeks before pollen season.
Choosing the most appropriate seasonal allergy medication depends on the pattern and severity of an individual's symptoms. A stepwise, symptom-led approach is generally recommended, in line with NICE CKS guidance on allergic rhinitis.
For mild, intermittent symptoms — particularly sneezing, itching, and rhinorrhoea — a non-sedating oral antihistamine taken as needed is usually sufficient. Cetirizine and loratadine are widely available and cost-effective. Fexofenadine (120 mg once daily for hay fever; licensed from age 12) is a useful alternative for those who experience drowsiness even with other second-generation antihistamines, as it has a particularly low sedation profile. Note that absorption of fexofenadine is significantly reduced by fruit juices (including grapefruit, orange, and apple juice); take it with water, not juice, as advised in the product information. For persistent symptoms, taking an antihistamine regularly each day (rather than only when needed) generally provides better control.
It is important to note that while antihistamines address histamine-mediated symptoms effectively, they have limited impact on nasal congestion.
For moderate-to-severe or persistent symptoms, particularly nasal blockage and congestion, an intranasal corticosteroid spray is the preferred option. These sprays must be used regularly — ideally starting 1–2 weeks before the pollen season begins — to achieve their full anti-inflammatory effect. Patients should be counselled on correct technique: direct the nozzle away from the nasal septum and sniff gently to keep the spray within the nose, reduce local irritation, and minimise throat run-off. Poor technique reduces efficacy and increases the risk of nosebleeds (epistaxis). Pharmacists can demonstrate correct use.
When eye symptoms are prominent, topical antihistamine or mast cell stabiliser eye drops provide targeted relief. Sodium cromoglicate drops are available OTC, are suitable for children (check age limits), and are particularly useful when started early in the season — they require dosing several times daily and may take a few days to reach full effect. Ketotifen eye drops are another OTC option. For combined nasal and ocular symptoms, a combination of an intranasal corticosteroid and an appropriate eye drop often provides the most comprehensive control.
Combination intranasal antihistamine plus corticosteroid sprays (azelastine/fluticasone) are available on prescription, are generally licensed from age 12, and may benefit patients with more complex or poorly controlled symptom profiles.
NHS and NICE Guidance on Treating Hay Fever and Allergies
NICE recommends intranasal corticosteroids as first-line treatment for moderate-to-severe allergic rhinitis, advises against sedating antihistamines and depot corticosteroid injections, and supports immunotherapy referral for refractory cases.
NICE Clinical Knowledge Summaries (CKS) on allergic rhinitis provide clear, evidence-based guidance for the management of hay fever in the UK. According to NICE, intranasal corticosteroids are the most effective treatment for persistent or moderate-to-severe allergic rhinitis and should be offered as first-line therapy in these cases. For mild or intermittent symptoms, a non-sedating oral antihistamine is appropriate.
NICE and NHS guidance both advise against the routine use of first-generation (sedating) antihistamines such as chlorphenamine for hay fever, particularly in individuals who drive, operate machinery, or need to maintain concentration — including students during examination periods. The MHRA has also issued guidance highlighting the risks of sedation and impaired psychomotor performance associated with these older agents.
Depot intramuscular corticosteroid injections should not be offered for the treatment of hay fever, and routine oral corticosteroids are not recommended. In rare, exceptional circumstances — for example, a very important life event during peak pollen season — a short course of oral corticosteroids may be considered under specialist or GP supervision, at the lowest effective dose and for the shortest possible duration.
For children, NICE recommends:
-
Loratadine or cetirizine as first-line oral antihistamines (both licensed for children from age 2; check age-appropriate formulations and doses in the BNF or product information)
-
Intranasal corticosteroids for moderate-to-severe symptoms, with appropriate age-based dosing
-
Referral to a paediatric allergist if symptoms are poorly controlled or if allergic asthma coexists
NICE also supports referral for allergen immunotherapy in selected patients with confirmed IgE-mediated allergic rhinitis who have not responded adequately to optimised pharmacotherapy (intranasal corticosteroid with or without add-on treatments). Both subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) are recognised options, though availability on the NHS varies by region. Immunotherapy must be initiated and supervised by a specialist with appropriate facilities for managing adverse reactions.
Clearer referral triggers include: failure to achieve adequate control despite optimised intranasal corticosteroid therapy with add-ons, significant impact on school or work performance despite treatment, severe or persistent ocular involvement, or coexisting poorly controlled asthma.
Patients should be encouraged to use the NHS 111 service or consult their GP if symptoms are severe, if there is associated wheeze or breathlessness, or if OTC treatments have failed after two weeks of consistent use.
How to Use Allergy Medications Safely and Effectively
Starting intranasal corticosteroids 1–2 weeks before pollen season, using correct nasal spray technique, avoiding fruit juice with fexofenadine, and limiting decongestant sprays to 7 days are key steps for safe, effective allergy treatment.
Using seasonal allergy medications correctly is essential to maximise their benefit and minimise the risk of side effects. Several practical principles apply across the main medication classes.
Non-pharmacological measures are an important complement to medication. These include checking daily pollen forecasts (e.g., via the Met Office), staying indoors or keeping windows closed on high-pollen days, showering and changing clothes after being outdoors, wearing wraparound sunglasses, and using saline nasal irrigation to help clear allergens from the nasal passages. NICE and NHS guidance recommend these measures alongside pharmacotherapy.
Starting treatment early is one of the most effective strategies. For predictable seasonal allergies, beginning an intranasal corticosteroid spray 1–2 weeks before the expected pollen season — and continuing it throughout — provides significantly better symptom control than reactive use. Similarly, antihistamines taken before known allergen exposure (e.g., before spending time outdoors on high-pollen days) can blunt the allergic response.
Key safety considerations include:
-
Drowsiness: Even second-generation antihistamines can occasionally cause sedation in susceptible individuals. Patients should assess their response before driving or operating machinery. Avoid alcohol if taking any antihistamine, particularly sedating (first-generation) ones.
-
Fexofenadine and fruit juice: Take fexofenadine with water only — fruit juices (grapefruit, orange, apple) significantly reduce its absorption.
-
Pregnancy and breastfeeding: Loratadine or cetirizine are generally the preferred oral antihistamines during pregnancy, based on UK Teratology Information Service (UKTIS/BUMPS) guidance. Intranasal corticosteroids such as beclometasone or budesonide may also be used during pregnancy. Always seek pharmacist or GP advice before starting any medication during pregnancy or whilst breastfeeding.
-
Drug interactions: Some antihistamines interact with CNS depressants, including alcohol and certain sedative medicines. Patients taking multiple medications should seek professional advice.
-
Nasal spray technique: Direct the nozzle away from the nasal septum and sniff gently to keep the spray in the nose and reduce irritation, epistaxis, and throat run-off. Pharmacists can demonstrate correct use.
-
Prolonged decongestant use: Nasal decongestant sprays should not exceed 7 consecutive days. Oral decongestants should not be used in children under 12, or in pregnancy or breastfeeding, unless specifically advised by a clinician.
-
Pseudoephedrine safety: Stop use and seek urgent medical attention if you develop a sudden, severe headache or neurological symptoms whilst taking pseudoephedrine (see MHRA/EMA safety advice on RCVS/PRES).
Patients should seek GP advice if:
-
Symptoms are not controlled after 2–4 weeks of appropriate OTC treatment
-
There is associated asthma, facial pain (suggesting sinusitis), or significant sleep disturbance
-
Symptoms occur year-round, suggesting perennial rather than seasonal allergy
Reporting side effects: If you experience a suspected side effect from any allergy medication, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app. This helps the MHRA monitor the safety of medicines used in the UK.
With the right medication, used correctly and at the right time, and supported by practical allergen-avoidance measures, the vast majority of people with seasonal allergies can achieve good symptom control and maintain their quality of life throughout the pollen season.
Frequently Asked Questions
What is the most effective seasonal allergy medication available in the UK?
According to NICE Clinical Knowledge Summaries, intranasal corticosteroid sprays (such as beclometasone or fluticasone) are the most effective single treatment for moderate-to-severe hay fever. For mild or intermittent symptoms, a non-sedating oral antihistamine such as cetirizine or loratadine is usually sufficient.
Can I take hay fever medication during pregnancy?
Loratadine or cetirizine are generally the preferred oral antihistamines during pregnancy, based on UK Teratology Information Service (UKTIS/BUMPS) guidance, and intranasal corticosteroids such as beclometasone or budesonide may also be used. Always consult your pharmacist or GP before starting any allergy medication during pregnancy or whilst breastfeeding.
When should I see a GP about my seasonal allergy symptoms?
You should consult a GP if your symptoms are not controlled after 2–4 weeks of appropriate over-the-counter treatment, if you have associated wheeze or breathlessness, or if symptoms occur year-round. Seek urgent medical help if you experience severe breathlessness, swelling of the lips or throat, or sudden severe headache.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
